Key facts
- It has raised $11.5M; the latest was Later Stage VC ($7.2M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, SBI Investment, SparkLabs Group, Korea Technology Finance, KDB Capital — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for EXOSYSTEMS
- ·The full record, as it builds
Funding rounds
No funding rounds for EXOSYSTEMS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EXOSYSTEMS
Developer of a digital healthcare company designed to provide AI-powered care for musculoskeletal and neuromuscular health. The company's platform offers wearable medical devices that collect muscle biosignals, AI-driven analysis for personalized rehabilitation, and remote therapeutic monitoring, enabling patients and healthcare providers to manage musculoskeletal disorders effectively and efficiently.
- Sector
- Healthcare
- HQ
- Seongnam, South Korea
- Founded
- 2017
- Employees
- 23
- Website
- exosystems.io/
- Ownership
- Privately Held (backing)
EXOSYSTEMS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EXOSYSTEMS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EXOSYSTEMS in its N-PORT filings yet. We sweep new filings monthly.